Wegovy, a well-known medication for weight loss, is sold in China

 

Weight loss treatment becomes available to more than 180 million people living with obesity in China

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June.
It is set to intensify competition with rival Eli Lilly, whose popular weight-loss treatment also got the green light months ago but has yet to go on sale in the world's second largest pharmaceutical market.
More than 180 million people live with obesity in China, which has a population of 1.4 billion.
According to Chinese business news website Yicai, a dose of four Wegovy injections will cost 1,400 yuan (£153; $194), a fraction of the drug's price in the United States.